Ernie Meyer

Human Resources Officer presso ULTRAGENYX PHARMACEUTICAL INC.

60 anni

Health Technology

Consumer Services

Profilo

Ernie Meyer is currently the Chief Human Resources Officer & Executive VP at Ultragenyx Pharmaceutical, Inc. He previously worked as the Executive VP-Human Resources & Corporate Services at Celgene Corp.
from 2014 to 2016.
He also held the position of Chief Human Resources Officer & Executive VP at Portola Pharmaceuticals LLC.
Mr. Meyer completed his undergraduate degree at Widener University.

Posizioni attive di Ernie Meyer

Società	Posizione	Inizio
ULTRAGENYX PHARMACEUTICAL INC.	Human Resources Officer	01/09/2020

Tutte le posizioni attive di Ernie Meyer

Precedenti posizioni note di Ernie Meyer

Società	Posizione	Fine
CELGENE	Human Resources Officer	01/01/2016
PORTOLA PHARMACEUTICALS, INC.	Human Resources Officer	-

Vedi nel dettaglio l'esperienza di Ernie Meyer

Formazione di Ernie Meyer

Widener University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ernie Meyer

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ULTRAGENYX PHARMACEUTICAL INC.	Health Technology

Aziende private	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology